Jornal de Bioterrorismo e Biodefesa

Abstrato

New Biosensing Technology for Better COVID-19 and Future Pandemic Diagnoses

Joshua Wiedermann

Individual tools play significant places in the fight against COVID- 19 and other afflictions. Being tests, similar as RT- qPCR, have limitations including long assay time, low outturn, shy perceptivity, and sour portability. Arising biosensing technologies hold the pledge to develop tests that are rapid-fire, largely sensitive, and suitable for pointof- care testing, which could significantly grease the testing of COVID- 19. Despite that, practical operations of similar biosensors in afflictions have yet to be achieved. In this review, we consolidate the recently developed individual tools for COVID- 19 using arising biosensing technologies and bandy their operation pledge. In particular, we present nucleic acid tests and antibody tests of COVID- 19 grounded on both conventional and arising biosensing styles. We also give perspectives on the being challenges and implicit results.